Theralase Technologies Inc. (TSXV:TLT)

Theralase Technologies Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 2, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	76	66	40	69	77	39
Market Cap Growth	17.24%	64.23%	-42.29%	-9.56%	97.37%	-44.12%
Enterprise Value	76	66	40	67	72	30
Last Close Price	0.28	0.27	0.17	0.32	0.38	0.19
PS Ratio	75.45	63.54	37.35	60.85	98.13	41.77
PB Ratio	69.12	31.76	20.98	22.40	15.11	4.24
P/TBV Ratio	69.12	31.76	20.98	22.40	15.11	4.24
EV/Sales Ratio	75.69	63.53	37.52	59.13	91.82	32.43
Debt / Equity Ratio	0.29	0.14	0.20	0.15	0.01	0.01
Net Debt / Equity Ratio	0.22	0.01	0.18	-0.33	-0.72	-0.85
Net Debt / EBITDA Ratio	-0.06	-0.01	-0.08	0.21	0.85	1.42
Net Debt / FCF Ratio	-0.09	-0.01	-0.08	0.20	0.89	1.69
Asset Turnover	0.32	0.32	0.29	0.23	0.10	0.07
Inventory Turnover	0.82	0.80	0.89	0.97	0.92	1.17
Quick Ratio	0.50	0.99	0.60	2.86	4.56	10.18
Current Ratio	0.83	1.61	1.39	3.67	5.71	10.85
Return on Equity (ROE)	-269.41%	-214.26%	-182.91%	-128.27%	-61.98%	-48.64%
Return on Assets (ROA)	-88.50%	-82.17%	-77.21%	-64.71%	-35.56%	-28.06%
Return on Capital Employed (ROCE)	-365.60%	-189.70%	-208.90%	-150.40%	-89.60%	-62.20%
Earnings Yield	-5.76%	-6.48%	-11.43%	-7.56%	-5.76%	-14.42%
FCF Yield	-3.46%	-5.10%	-10.28%	-7.47%	-5.39%	-11.88%
Buyback Yield / Dilution	-8.38%	-9.14%	-5.79%	-1.79%	-	-41.19%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.